This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hawsawi, N. M. Articles by Aboussekhra, A. Search for Related Content PubMed PubMed Citation Articles by Hawsawi, N. M. Articles by Aboussekhra, A.

Breast Carcinoma–Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes

¹ Department of Biological and Medical Research, ² Tumor Immunology/Stem Cell Therapy Program, ³ Department of Pathology, and ⁴ Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Requests for reprints: Abdelilah Aboussekhra, King Faisal Specialist Hospital and Research Center, BMR, MBC 03-66, P.O. Box 3354, Riyadh 11211, Saudi Arabia. Phone: 966-1464-7272; Fax: 966-1-442-7858; E-mail: aboussekhra{at}kfshrc.edu.sa.

Key Words: breast cancer • myofibroblasts • gene expression • p53/p21 pathway • survivin

It has become clear that the initiation and progression of carcinomas depend not only on alterations in epithelial cells, but also on changes in their microenvironment. To identify these changes, we have undertaken cellular and molecular characterization of carcinoma-associated fibroblasts (CAF) and their tumor counterpart fibroblasts (TCF) isolated from 12 breast cancer patients. Normal breast fibroblasts (NBF) from plastic surgery were used as normal control. We present evidence that both CAFs and TCFs are myofibroblasts and show tumor-associated features. Indeed, the p53/p21 response pathway to -rays was defective in 70% CAFs, whereas it was normal in all the TCF and NBF cells. In addition, the basal levels of the p53 and p21 proteins were significantly low in 83% of CAFs and modulated in the majority of TCFs compared with NBFs. Interestingly, both TCFs and CAFs expressed high levels of the cancer marker survivin and consequently exhibited high resistance to cisplatin and UV light. Moreover, most CAFs were positive for the proliferation marker Ki-67 and exhibited high proliferation rate compared with NBFs and TCFs. However, proliferating cell nuclear antigen was highly expressed in both CAFs and TCFs. Using the two-dimensional gel electrophoresis technique, we have also shown that CAF, TCF, and NBF cells present different proteome profiles, with many proteins differentially expressed between these cells. Taken together these results indicate that different genetic alterations can occur in breast CAFs and their corresponding adjacent counterparts, showing the important role that stroma could play in breast carcinogenesis and treatment. [Cancer Res 2008;68(8):2717–25]

This article has been cited by other articles:

				H Chang, N Mohabir, S Done, and P A Hamel Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer J. Clin. Pathol., October 1, 2009; 62(10): 908 - 914. [Abstract] [Full Text] [PDF]

				N. Paland, I. Kamer, I. Kogan-Sakin, S. Madar, N. Goldfinger, and V. Rotter Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer Mol. Cancer Res., August 1, 2009; 7(8): 1212 - 1223. [Abstract] [Full Text] [PDF]

				S. M. Eck, A. L. Cote, W. D. Winkelman, and C. E. Brinckerhoff CXCR4 and Matrix Metalloproteinase-1 Are Elevated in Breast Carcinoma-Associated Fibroblasts and in Normal Mammary Fibroblasts Exposed to Factors Secreted by Breast Cancer Cells Mol. Cancer Res., July 1, 2009; 7(7): 1033 - 1044. [Abstract] [Full Text] [PDF]

				Y.-L. Zheng, N. Hu, Q. Sun, C. Wang, and P. R. Taylor Telomere Attrition in Cancer Cells and Telomere Length in Tumor Stroma Cells Predict Chromosome Instability in Esophageal Squamous Cell Carcinoma: A Genome-Wide Analysis Cancer Res., February 15, 2009; 69(4): 1604 - 1614. [Abstract] [Full Text] [PDF]

				P. J. Mishra, P. J. Mishra, J. W. Glod, and D. Banerjee Mesenchymal Stem Cells: Flip Side of the Coin Cancer Res., February 15, 2009; 69(4): 1255 - 1258. [Abstract] [Full Text] [PDF]